Girish Venkataraman to Prognosis
This is a "connection" page, showing publications Girish Venkataraman has written about Prognosis.
Connection Strength
0.379
-
Challenges in the Diagnosis of Gray Zone Lymphomas. Surg Pathol Clin. 2019 Sep; 12(3):709-718.
Score: 0.100
-
Current status of prognostication in classical Hodgkin lymphoma. Br J Haematol. 2014 May; 165(3):287-99.
Score: 0.069
-
Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival. Blood. 2013 Mar 07; 121(10):1795-804.
Score: 0.064
-
CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Bruton's Tyrosine Kinase Inhibition. J Clin Oncol. 2024 Feb 01; 42(4):467-480.
Score: 0.034
-
A case of dual-mechanism immune-related anaemia in a patient with metastatic melanoma treated with nivolumab and ipilimumab. J Immunother Cancer. 2020 03; 8(1).
Score: 0.026
-
Rosai-Dorfman Disease of the Breast With Variable IgG4+ Plasma Cells: A Diagnostic Mimicker of Other Malignant and Reactive Entities. Am J Surg Pathol. 2019 12; 43(12):1653-1660.
Score: 0.026
-
Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma. Blood Adv. 2019 10 08; 3(19):2790-2799.
Score: 0.026
-
Burkitt leukemia limited to the bone marrow has a better prognosis than Burkitt lymphoma with bone marrow involvement in adults. Leuk Lymphoma. 2016; 57(4):866-71.
Score: 0.019
-
Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood. 2011 May 05; 117(18):4726-35.
Score: 0.014